ONO PHARMA USA Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • ONO PHARMA USA's estimated annual revenue is currently $25.7M per year.(i)
  • ONO PHARMA USA's estimated revenue per employee is $186,435

Employee Data

  • ONO PHARMA USA has 138 Employees.(i)
  • ONO PHARMA USA grew their employee count by 20% last year.

ONO PHARMA USA's People

NameTitleEmail/Phone
1
Senior Manager, Quality AssuranceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$413.3M3240%$634MN/A
#2
$47.8M2380%N/AN/A
#3
$2.4M8-20%N/AN/A
#4
$25.7M13820%N/AN/A
#5
$12.9M64129%N/AN/A
#6
$23.9M1198%$113MN/A
#7
$0.3M30%N/AN/A
#8
$10.3M41-2%N/AN/A
#9
$1.8M367-4%$538MN/A
#10
$50M192-7%N/AN/A
Add Company

What Is ONO PHARMA USA?

ONO PHARMA USA, INC. (OPUS) was established in 1998 as the US subsidiary of Ono Pharmaceutical Co., Ltd. (ONO), an R&D-oriented pharmaceutical company founded in 1717 with headquarters in Osaka, Japan. For more than 300 years ONO has made progress in our commitment to relieve patients' pain, focus on their health improvement and succeed in delivering \First in class\ medicines, such as OPDIVO® (nivolumab), to patients. OPUS is pursuing overseas clinical trials of our new drug candidates and continuously and vigorously promotes licensing activities as a potential means of expanding our development pipeline and globally marketing new drugs that we develop.

keywords:N/A

N/A

Total Funding

138

Number of Employees

$25.7M

Revenue (est)

20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$34.5M138-6%$338M
#2
$26.4M13821%N/A
#3
$35.1M13810%N/A
#4
$16.3M1386%$239.4M
#5
$25.7M13820%N/A